| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |